Business Wire

Energy Storage Company Fluence Unveils SunFlex Energy Storage, its New Technology Platform for Solar PV


Fluence, an energy storage company owned by Siemens and The AES Corporation, announced its new technology platform, called SunFlex Energy Storage, that both improves and expands the capabilities of photovoltaic solar generation, already the fastest growing resource in the power sector. The company's newest energy storage technology platform enables solar facilities to sell up to 50 percent more clean energy per site, eliminates solar variability across the day – such as that caused by passing clouds – and expands the delivery of energy into the night, creating an on-demand solar resource.

“Solar and energy storage are the cheapest way to provide power in a number of markets today, and will reach economic parity in many more countries over the next five years,” said Stephen Coughlin, president and CEO of Fluence. "With Fluence’s SunFlex Energy Storage platform, customers can now deliver clean, abundant and low-cost solar energy on-demand, day or night.”

The growth in solar generation globally has been remarkable with the share of photovoltaics as a percentage of total generation doubling seven times between 2000 and 2015, according to Bloomberg New Energy Finance. However, the industry faces headwinds as increasing solar generation creates challenges for network operators, tasked with controlling system reliability, to manage the uncertainty caused by this variable resource. With Fluence's new technology platform, solar energy can now be delivered when it is needed most, not just when it is available. This innovation eliminates the need for back-up generation, such as peaking gas plants or reciprocating engines, to manage solar variability. This is especially critical on many microgrids and islands, where solar and storage combined are now the cheapest and most reliable form of energy available.

"The Fluence team originally developed energy storage solutions to replace inefficient or underutilized traditional power infrastructure assets such as power reserves, peaking, or wires," said John Zahurancik, COO of Fluence. “Today, as new power investment is flowing mainly into new solar generation, we have the chance to make this more efficient from the start. With our solution, we can get more solar energy from the same site and make the best use of our power networks.”

The Fluence SunFlex Energy Storage technology platform builds upon many of the industry-leading controls and architectural principles from Advancion and Siestorage, the company’s two technology platforms and the experience gained from working with leading solar developers such as sPower and AES Distributed Energy. The new platform captures the solar energy that otherwise would be lost during daily peak solar hours, and will increase the volume of energy delivered from a single site by up to 50 percent by allowing developers to add more solar panels without the cost of changing their interconnection. In addition, the new platform improves plant stability by smoothing and limiting the ramping of solar output, and in many areas, simplifies the interconnection process for combined solar and storage facilities. These improvements are only available from tailored energy storage solutions like Fluence’s SunFlex Energy Storage platform. In addition, energy storage can expand the capabilities of solar facilities by increasing the capacity factor of the plant and adding new sources of revenue from frequency regulation and other grid services.

With 10 years of experience and nearly 500 MW of energy storage projects deployed or awarded, Fluence is the leading energy storage technology and services company. Fluence combines the experience, talent and backing of industry giants and storage market leaders Siemens and AES to offer an unparalleled suite of energy storage capabilities. The Fluence team focuses on solving customers’ energy problems and prioritizing lasting partnerships over simply delivering products.

Learn more about Fluence, its team, and its new technology and service offerings at

About Fluence

Fluence, a Siemens and AES company, is a global energy storage technology solutions and services company that combines the agility of a technology company with the expertise, vision, and financial backing of two industry powerhouses. As the successor to industry pioneers AES Energy Storage and Siemens energy storage, Fluence’s goal is to create a more sustainable future by transforming the way we power our world. The company offers proven energy storage technology solutions designed to address the diverse needs and challenges of customers in a rapidly transforming energy landscape, providing design, delivery and integration in over 160 countries. Fluence works closely with customers throughout their journey and provides advisory, financing, and project lifecycle services. To date, Fluence’s teams have deployed or been awarded a market-leading 56 projects with a total capacity of 485 MW in 15 countries. To learn more, visit and follow Fluence on Twitter at @FluenceEnergy.

Contact information

Steven Goldman, 703-721-8673

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 21:28Tiedote

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 19:05Tiedote

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 15:52Tiedote

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 15:50Tiedote

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 15:46Tiedote

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 15:00Tiedote

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme